news
Tumours detected with sugar molecules
Scientists have synthesised a complex sugar structure that specifically binds to the tumour protein Galectin-1...
List view / Grid view
Drug Discovery
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
webinar
Skin toxicity mechanisms associated with mGluR5 negative allosteric modulators
11 August 2017 | By DiscoverX
In this webinar, DiscoverX Corporation discuss three negative allosteric modulators of metabotropic glutamate receptors, developed by Pfizer, which recently failed in preclinical development due to delayed type IV skin hypersensitivity observed in non-human primates...
news
New headquarters in Scotland strengthens drug discovery research
A provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture has opened its European headquarters in Glasgow, UK...
news
New antibiotic class found effective against gonorrhoea
Researchers have tested samples of N. gonorrhoeae from patients with infections in the throat, urethra, cervix and rectum, they found that at very low amounts closthioamide was effective...
news
MRC forges two new deals with industry to speed drug discovery
The Medical Research Council has formed partnerships with UCB and AstraZeneca, the deals will help speed translation of discovery research into potential therapies...
news
Hamish Ryder joins Drug Target Review Advisory Board
Prior to joining CRT-DL, Dr Ryder held positions in pharmaceutical and biotech companies for over 20 years ...
news
Study identifies new brain death pathway in Alzheimer’s disease
Evidence that the activation of a biological pathway necroptosis is closely linked with Alzheimer's...
news
Orphan drug market to double as Pharma rethinks business model
Market intelligence suggests pharma is being forced to shift focus towards niche patient populations and orphan diseases ...
news
Takeda launches contract R&D firm AXCELEAD
Takeda has launched a contract research and development company, AXCELEAD, at its Shonan Research Centre.
news
£8500 given to cancer research at the University of Warwick
Cancer research at the University of Warwick has received a boost thanks to the former Lord Mayor of Coventry Cllr Lindsley Harvard.
news
New biomarker shows promise for pitch-side brain injury test
Researchers at the University of Birmingham have identified inflammatory biomarkers which indicate whether the brain has suffered injury.
news
£2m grant for University collaboration antibiotic resistance study
Dr Reda Lebcir from the University of Hertfordshire is part of an international team of researchers awarded a £2m grant from the ESRC (Economic and Social research Council).
news
New study reveals new drug target for gout & inflammatory diseases
Research reveals cathepsins as potential therapeutic targets in particulate-mediated inflammatory disease…
news
Solution to accelerate drug discovery process by DDI analysis
Elsevier has launched a new solution aimed at accelerating drug discovery through comprehensive prediction and assessment of drug-drug interactions (DDI).
article
Q&A: The role of disease focused foundations in bridging the drug discovery and development gap
Bio 2017 opens this week and Drug Target Review’s Niamh Marriott spoke with Richard Soll, Senior Vice President, Research Service Division, WuXi AppTec and Salvatore La Rosa, Vice President Research and Development, Children’s Tumor Foundation, to get their perspectives on one of the event’s most pressing trends. Both will be…